FDA Announces Recall of Apexxx Tablets

The U.S. Food and Drug Administration (FDA) has announced the recall of Nuway Distributors LLC’s Apexxx dietary supplement tablets, which were found to contain sildenafil, the active ingredient in an erectile dysfunction drug. Sildenafil is not listed on the Apexxx tablets’ product labels and may cause life-threateningly low blood pressure levels in patients taking nitrates.

All lots of Apexxx sold in 2014 to June 2015 are included in the recall, as well as Opal tablets, which were sourced from the same vendors as Apexxx. The FDA recommends that consumers and retailers stop using and distributing both products and return all lots.

Read the FDA announcement

Clinical Topics: Prevention, Nonstatins, Diet

Keywords: Blood Pressure, Blood Pressure Determination, Dietary Supplements, Erectile Dysfunction, Nitrates, United States Food and Drug Administration

< Back to Listings